Should you sell your shares if they report badly?

It’s finally reporting season and already there has been some negative reactions to some of the reports. For example, Credit Corp Group Limited (ASX: CCP) and Navitas Limited (ASX: NVT) have fallen by 5.83% and 8.02% respectively after reporting today.

However, both shares revealed very different results. The market is reacting to the expectations of what those two companies were going to report, not specifically the numbers themselves.

Was it Credit Corp’s fault for not delivering on expectations or the market’s fault for expecting too much?

Either way, it can be hard knowing what to do if you own shares and they go down on report day. Perhaps the market is right and it’s time to sell? Perhaps investors should just hold? Maybe the share price drop means it’s now a buying opportunity?

Unless investors are planning on never selling their shares, or holding for extremely long periods of time, I think it’s worth asking ‘what would I do at today’s price if I didn’t own this share?’.

Investors can become anchored to the buying price of their shares, but the market doesn’t care what price you paid – it all depends on the future of the business. If you think that your share has good prospects at today’s price then it could be worth buying more. If you think the business is still overvalued and doesn’t have a good future then it could be worth selling.

It also depends on your original investment thesis. I don’t mind if Ramsay Health Care Limited (ASX: RHC) has one bad report because I expect it to grow steadily over many years. That’s why ‘ignoring the noise’ can be such good advice, most investors are investing with much shorter timeframes.

Foolish takeaway

I hope reporting season is more positive than it has been so far and I hope your shares do well. I’m confident in all of the shares that I own for the long-term, so I’ll be looking for any bargains if they show up.

I expect that these hot stocks could report very well next month.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Ramsay Health Care Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.